Beaconcure Appoints Seth Houston as Chief Executive Officer

Houston will lead the company's next phase of growth as more life sciences organizations adopt artificial intelligence to improve the quality, speed, and efficiency of clinical development.

Seth Houston has more than 25 years of leadership experience in healthcare technology, enterprise software, and the life sciences industry. He has held senior executive roles focused on driving business growth and innovation.

Throughout his career, Houston has built commercial teams, developed strategic partnerships, and helped pharmaceutical and medical technology companies use software solutions to improve operations and better serve their customers.

Read More:Corgi Insurance Appoints Robert E. Barlow Jr. as EVP of Partnerships

Before joining Beaconcure, Seth Houston served as Chief Commercial Officer at MediSpend, where he led the company's global commercial operations, including sales, account management, solution engineering, partnerships, and marketing.

Earlier in his career, he held executive leadership roles at IQVIA, OpenQ, Wolters Kluwer Health, and Proscape Technologies. In these roles, he helped life sciences companies modernize their operations using SaaS platforms and data-driven technology solutions.

"I'm honored to join Beaconcure at such an exciting time for both the company and the industry," said Seth Houston, Chief Executive Officer of Beaconcure. "AI is transforming the way life sciences organizations develop and deliver new therapies and Beaconcure is uniquely positioned to help customers adopt these technologies with confidence. Our platform combines innovation with the quality, transparency, and governance required in regulated environments.

About Beaconcure

Founded in 2016 by Ilan Carmeli, Beaconcure develops AI solutions that help biopharmaceutical companies and contract research organizations (CROs) improve clinical development. Its Verify platform helps teams review, validate and manage clinical data more efficiently while maintaining the quality, accuracy and regulatory compliance required in the life sciences industry.

Read More:Runestone Partners With Raidiant To Power Gender-Inclusive